Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
In a phase 2, randomized, double-blind, placebo-controlled trial (NCT04881760) involving adults with obesity without type 2 diabetes, retatrutide (1 mg12 mg weekly) produced dose-dependent weight loss of up to 24.2% from baseline at 48 weeks, compared with 2.1% with placebo
Your batch is inspected, labeled, and sealed
Research ArticleEndocrinologyMetabolism Open Access | 10.1172/jci.insight.141851 1 Department of Biomedical Sciences and 2 Baker Institute for Animal Health, Cornell University College of Veterinary Medicine, Ithaca, New York, USA
Earn 695 Points when you buy this item
/assets/images/provider/photos/2775905.jpeg)
US$ 26.80
US$ 27.75
US$ 25.40
US$ 22.49
:max_bytes(150000):strip_icc()/VWH-GettyImages-1661265589-f2a312a0dfb64367b0f6e40194ebf18f.jpg)
